Japan Healthcare: Currency Benefit Seems to Be Fading; Focus Will Be on Underlying Business Strength
As Yen is recovering from its multi-year lows against Dollar this year, export-oriented healthcare companies are expected to significantly...
441 Views
Global Medtech Trends: Readouts from Early Birds of Q3 Earnings Season- Positives and Negatives
Q3 results of large U.S. medtech companies recorded procedure volume growth. However, macroeconomic headwinds are expected to prevail. Similar...
348 Views
Datamining Tech Publications to Assess Shockwave's Paradigm Shift Solution In Vascular Interventions
Shockwaveβs intravascular lithotripsy product could become a game changer in dealing withΒ coronary calcium and may offer a more effective solution...
582 Views
Archion (543A JP): The Current Playbook
The preliminary pricing range is JPY250 to JPY300 per share. The offering will likely be priced on 22 July. The average large Japanese placement...
181 Views
π―π΅ JAPAN β’ Results & Revisions 11/βββββββββββββββββββββββ05 Tsumura, Sysmex, Terumo, Nintendo, MRE
β’ BEST & WORST β’ Thursday's best and worst pairing is herbal medicine specialist Tsumura (4540 JP) and our'Suga Short' recommendation Mitsui...
517 Views